Diabetes drug moves Parkinson's treatment a step closer
A common diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research suggests.
A common diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research suggests.
Every year, 24,000 people with diabetes die simply because their disease has not been effectively managed, MPs have said.
Diabetes costs the NHS almost £12 billion a year and it's getting worse. New research says certain ethnic groups are most vulnerable.
A new device which acts like an artificial pancreas could be set to transform the lives of people who suffer from Type 1 diabetes.
A sensor relays information about blood glucose levels to a monitor which, in turn, tells a pump within the body how much insulin to dispense.
ITV News reporter Martha Fairlie met a patient testing the technology:
Doctors believe a drug used to treat diabetes could significantly help people suffering from Parkinson's Disease.
Tests on the drug are still in their very early stages, but initial results suggest it might combat aspects of the physical degeneration caused by the disease.
ITV News reporter Ben Chapman reports:
Read: Diabetes drug moves Parkinson's treatment a step closer
Parkinson's UK have said it is "too soon to know effects" the common diabetes drug Exenatide will have on the treatment of Parkinson's disease.
– Claire Bale, Research Communications Manager at Parkinson’s UKThis new research is a huge step forward in the on-going fight to find a drug which can slow down, or even halt, the progression of Parkinson's.
Despite these encouraging results, it is simply too soon to tell whether this drug is a blind alley or a breakthrough for people with Parkinson's.
The research was conducted in a very small number of people and, crucially, without a placebo group – making it difficult to draw too many firm conclusions at this stage.
We look forward to seeing the results of a much larger trial to fully examine the usefulness of exenatide for people with Parkinson's.
A diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research has found.
– Professor Roger Barker, University of CambridgeThis new study is perhaps more noteworthy for the approach it has taken with respect to the clinical trial design.
All of this was done in a modest number of patients and the results compared with a matched control arm that received best medical therapy.
Using this approach they found a signal of effect that suggested that the drug may well be slowing down the disease process.
All of which is good news not only for patients with PD but for us all, as we seek to explore how drugs already out there could be repositioned.
A common diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research suggests.
Read the full storyThe study was carried out by the Journal of Clinical Investigation.
Source: Parkinson's UK
A common diabetes drug could be beneficial for the treatment of Parkinson's disease, new research suggests.
Exenatide is a drug commonly used to treat diabetes, however new research suggests that the drug may potentially be able to slow down the progression of Parkinson’s.
Research published by the Journal of Clinical Investigation shows that after one year of treatment, patients receiving the drug displayed improved cognitive ability and motor skills, while control patients declined.
The main symptoms of undiagnosed diabetes can include:
In Type 1 diabetes the signs and symptoms are usually very obvious and develop very quickly, typically over a few weeks. The symptoms are quickly relieved once the diabetes is treated and under control.
In Type 2 diabetes the signs and symptoms may not be so obvious, as the condition develops slowly over a period of years and may only be picked up in a routine medical check up. Symptoms are quickly relieved once diabetes is treated and under control.
Barbara Young, chief executive of Diabetes UK, has accused the healthcare system of being "all too often not good enough" when tackling diabetes.
People with diabetes needed self-management support programmes, along with ongoing medical support and education if they were to avoid complications and reduce the risk of early death, she added.
– Baroness YoungGiven that diabetes is serious and can lead to early death if not supported to manage their condition, it is extremely worrying that so few people have it under control.
When you consider that there are now three million people diagnosed with diabetes and this number is rising quickly, the fact that so many of them do not have good control over their diabetes means that unless something changes we face a public health disaster.